HIGHLIGHTS
SUMMARY
In the specialised area of mental health (MH), MH-HiTH programs support the patient in all aspects of their treatment, including non-MH medical issues and psychosocial issues. Daily medication review, accurate adverse drug reaction (ADR) documentation, patient counselling and therapeutic drug monitoring (TDM) are some of the strategies employed by the CP in the HiTH setting to improve medication safety and contribute to better patient outcomes. As psychotropic medications are recognised as high risk medications, the Australian Commission on Safety and Quality in Health Care has recommended further adaptation of existing clinical pharmacy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.